MedPath

山东齐鲁制药有限公司

Ownership
-
Established
1992-08-21
Employees
-
Market Cap
-
Website
https://www.qilu-pharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

497

NMPA:497

Drug Approvals

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets(Ⅲ)

Product Name
达格列净二甲双胍缓释片(Ⅲ)
Approval Number
国药准字H20253378
Approval Date
Feb 11, 2025
NMPA

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets(Ⅰ)

Product Name
达格列净二甲双胍缓释片(Ⅰ)
Approval Number
国药准字H20253377
Approval Date
Feb 11, 2025
NMPA

Ixazomib Citrate Capsules

Product Name
枸橼酸伊沙佐米胶囊
Approval Number
国药准字H20253310
Approval Date
Jan 24, 2025
NMPA

Ciclosporin Soft Capsules

Product Name
环孢素软胶囊
Approval Number
国药准字H20253226
Approval Date
Jan 24, 2025
NMPA

Ciclosporin Soft Capsules

Product Name
环孢素软胶囊
Approval Number
国药准字H20253311
Approval Date
Jan 24, 2025
NMPA

Ixazomib Citrate Capsules

Product Name
枸橼酸伊沙佐米胶囊
Approval Number
国药准字H20253309
Approval Date
Jan 24, 2025
NMPA

Ixazomib Citrate Capsules

Product Name
枸橼酸伊沙佐米胶囊
Approval Number
国药准字H20253308
Approval Date
Jan 24, 2025
NMPA

Edoxaban Tosilate Tablets

Product Name
甲苯磺酸艾多沙班片
Approval Number
国药准字H20253108
Approval Date
Jan 8, 2025
NMPA

Edoxaban Tosilate Tablets

Product Name
甲苯磺酸艾多沙班片
Approval Number
国药准字H20253107
Approval Date
Jan 8, 2025
NMPA

Edoxaban Tosilate Tablets

Product Name
甲苯磺酸艾多沙班片
Approval Number
国药准字H20253109
Approval Date
Jan 8, 2025
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 50
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.